Singapore markets closed

AtriCure, Inc. (ATRC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
30.42+0.28 (+0.93%)
At close: 04:00PM EDT
30.00 -0.42 (-1.38%)
After hours: 06:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close30.14
Open30.00
Bid30.43 x 100
Ask30.47 x 200
Day's range29.61 - 30.58
52-week range27.92 - 59.61
Volume501,360
Avg. volume653,826
Market cap1.448B
Beta (5Y monthly)1.39
PE ratio (TTM)N/A
EPS (TTM)-0.66
Earnings date30 Apr 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est56.14
  • Business Wire

    AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

    MASON, Ohio, March 26, 2024--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 23rd Annual Needham Virtual Healthcare Conference.

  • Insider Monkey

    AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug

    TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the quarter the fund returned 9.15% (net), compared to a 12.75% return for the Russell 2000 Growth Index. For the year, the fund returned 15.96% (net) compared to […]

  • GuruFocus.com

    Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)

    Karl Dahlquist, Chief Legal Officer of AtriCure Inc (NASDAQ:ATRC), has sold 8,231 shares of the company on March 5, 2024, according to a recent SEC filing.